Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Stauffer

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Blood Cancer Journal|October 13, 2023
Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple modelsJelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, et al.
British Journal of Haematology|October 28, 2025
Outcome of T-cell/histiocyte-rich large B-cell lymphoma-A Danish nationwide matched cohort studyPeter Brændstrup, Thomas Bech Mortensen, Tarec Christoffer El-Galaly, et al.
Leukemia & Lymphoma|January 23, 2019
Depth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma - a nationwide population-based cohort studyMichael Roost Clausen, Sinna Pilgaard Ulrichsen, Thomas Stauffer Larsen, et al.
Leukemia & Lymphoma|January 9, 2026
Survival in mantle cell lymphoma patients burdened by a second primary malignancyKossi D Abalo, Trine Trab, Joachim Baech, et al.
British Journal of Haematology|May 16, 2025
Effectiveness of rituximab and biosimilar rituximab in untreated diffuse large B-cell lymphoma, a Danish population-based analysisAmal Haujir, Michael Tøstesen, Tarec Christoffer El-Galaly, et al.
Leukemia|October 23, 2022
Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCLSimon Husby, Cecilie Bæch-Laursen, Christian W Eskelund, et al.
Leukemia & Lymphoma|April 19, 2022
Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort studyMaja Bech Juul, Jelena Jelicic, Pavithra Laxsen Anru, et al.
European Journal of Haematology|September 11, 2024
A Real-World Data-Based Analysis of Prognostic Indices as Part of Trial Eligibility Criteria in Diffuse Large B-Cell Lymphoma PatientsJelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, et al.
Cancer Medicine|June 18, 2024
Revisiting beta-2 microglobulin as a prognostic marker in diffuse large B-cell lymphomaJelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 24, 2025
International Prognostic Models as Tools for Selection of Higher-risk Trial-eligible Patients With Diffuse Large B-Cell lymphomaJelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Blood Cancer Journal|October 13, 2023
Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple modelsJelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, et al.
British Journal of Haematology|October 28, 2025
Outcome of T-cell/histiocyte-rich large B-cell lymphoma-A Danish nationwide matched cohort studyPeter Brændstrup, Thomas Bech Mortensen, Tarec Christoffer El-Galaly, et al.
Leukemia & Lymphoma|January 23, 2019
Depth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma - a nationwide population-based cohort studyMichael Roost Clausen, Sinna Pilgaard Ulrichsen, Thomas Stauffer Larsen, et al.
Leukemia & Lymphoma|January 9, 2026
Survival in mantle cell lymphoma patients burdened by a second primary malignancyKossi D Abalo, Trine Trab, Joachim Baech, et al.
British Journal of Haematology|May 16, 2025
Effectiveness of rituximab and biosimilar rituximab in untreated diffuse large B-cell lymphoma, a Danish population-based analysisAmal Haujir, Michael Tøstesen, Tarec Christoffer El-Galaly, et al.
Leukemia|October 23, 2022
Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCLSimon Husby, Cecilie Bæch-Laursen, Christian W Eskelund, et al.
Leukemia & Lymphoma|April 19, 2022
Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort studyMaja Bech Juul, Jelena Jelicic, Pavithra Laxsen Anru, et al.
European Journal of Haematology|September 11, 2024
A Real-World Data-Based Analysis of Prognostic Indices as Part of Trial Eligibility Criteria in Diffuse Large B-Cell Lymphoma PatientsJelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, et al.
Cancer Medicine|June 18, 2024
Revisiting beta-2 microglobulin as a prognostic marker in diffuse large B-cell lymphomaJelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 24, 2025
International Prognostic Models as Tools for Selection of Higher-risk Trial-eligible Patients With Diffuse Large B-Cell lymphomaJelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, et al.
Pageof 11